PRTN3 and rheumatoid arthritis: Exploratory analysis revealed that improved RA disease activity was associated with the expansion of CII-specific and Cit-Vim-specific T-cells, a reduction in ACPA VDG, memory B cells, and inflammatory myeloid populations, and an enrichment in CCR7+ and naive T-cells.